Banks Enter Earnings Season Under a Cloud of Downgrades ๐Ÿ“‰

Next week, big banks kick off Q2 earnings season. But instead of bullish optimism, a wave of analyst downgrades has hit the sector. Oppenheimer recently downgraded Goldman Sachs (GS) and Morgan Stanley (MS) from 'Perform' to 'Underperform', and lowered Citigroup (C) and Bank of America (BAC) from 'Outperform' to 'Perform'.

The message is clear: current valuations are flush, and the market may be pricing in perfection that won't materialize. Here's the full bear case.

Bearish bank stock chart showing valuation risk Economic Flow Reference

Why Oppenheimer Says 'Take the Money and Run' ๐Ÿƒ๐Ÿ’ธ

According to Oppenheimer analysts, the risk/reward for large investment banks has become unfavorable. Their note states: "While the cycle may well go on for another 12-18 months or more, we'd rather not wait around for the warning signs to appear."

Key concerns include:

  • IPO Dependency: Investment banks like GS and MS have surged on hopes of a wave of IPOs (SpaceX, OpenAI, Anthropic). But higher bond yields and geopolitical tensions (Iran) could delay these catalysts.
  • Valuation Stretch: Both stocks have outperformed the broader banking group this year, leaving little room for upside surprises.
  • Credit Risk: If the Fed raises rates again, credit conditions could tighten, hurting both consumers and businesses.

This downgrade has split the Street. Here's how the bulls and bears are framing the debate:

๐Ÿฎ
Bull (Optimist)
This is a classic 'sell the rumor, buy the fact' setup. Q2 earnings will show strong IB revenue growth. The IPO pipeline is just delayed, not dead. SpaceX alone generated $86B in funding. Long-term holders should ignore the noise and accumulate on weakness. ๐Ÿ“ˆ
Bear (Pessimist)
Valuations are pricing in a perfect IPO cycle that may not arrive. OpenAI delaying its IPO is a red flag. With bond yields rising, the risk of a credit event is real. Oppenheimer is right โ€” better to take profits now than wait for warning signs. Take the money and run. ๐Ÿšจ
๐Ÿป

bank-stocks-downgrade-priced-for-perfection-q2-earnings-bear-case-C-year1-chart

Declining stock chart for bank sector Investment Psychology Art

The Data Behind the Downgrade ๐Ÿ“Š

MetricGoldman Sachs (GS)Morgan Stanley (MS)
YTD Performance+14%+11%
Q1 2026 IB Revenue Growth (YoY)+48%+36%
Current P/E vs 5-Year AvgAbove 90th PercentileAbove 85th Percentile
Analyst RatingUnderperform (New)Underperform (New)

Data source: YCharts, Oppenheimer Research.

โš ๏ธ Technical Insight: Both GS and MS are trading near their upper Bollinger Bands on the weekly chart, suggesting overbought conditions. A pullback to the 50-day moving average (around 5-7% downside) would not be surprising if earnings disappoint.

๐Ÿ“Š In-Depth Fundamental Analysis

CompanyShare PriceP/E RatioP/B RatioROEOperating Margin (OPM)Revenue Growth
ARES (Ares)$12256.0610.6914.18%18.43%28.30%
BAC (Bank)$5914.701.5310.64%35.96%8.10%
C (Citigroup,)$14017.251.247.65%34.08%15.90%
GS (Goldman)$1,05619.282.9614.55%38.60%14.50%
KKR (KKR)$9632.743.067.66%11.01%-6.60%
MS (Morgan)$22220.143.3616.39%40.62%16.30%
PNC (PNC)$25114.581.7512.10%36.73%13.80%
USB (U.S.)$6212.981.6512.35%37.84%4.60%

Analyst research report with downgrade stamp Financial Market Scene

Best vs. Worst Case Scenarios for Bank Stocks ๐ŸŽฏ

ScenarioConditionsImplication for GS/MS
๐ŸŸข Best CaseIPO wave resumes, Fed pauses, credit stableShort-term pop, but valuation remains stretched. Upside limited to 3-5%.
๐ŸŸก Base CaseMixed earnings, IPO delays continueGradual re-rating lower. Downside of 5-10% over 3 months.
๐Ÿ”ด Worst CaseFed hikes, credit losses rise, IPO freezeSharp sell-off. Downside of 15-20% as growth premium evaporates.

The Playbook: Oppenheimer suggests rotating into super-regionals (USB, PNC) and alternative asset managers (ARES, KKR) which offer better value and expansion potential.

Federal Reserve interest rate decision impact on banks Asset Management Illustration

This content was drafted using AI tools based on reliable sources, and has been reviewed by our editorial team before publication. It is not intended to replace professional advice.